| The Challenge of BCL-2 Resistance in CLL: Treatment Strategies and Emerging Therapies | 04/12/2025 | |
| Overcoming Disease Progression in CLL: Evidence-Based Re-treatment Considerations | 04/09/2025 | |
| Fixed-Duration Therapy in the Relapsed/Refractory CLL Setting | 04/13/2025 | |
| Combination Therapy in CLL: Identifying the Right Patient for the Right Treatment Approach | 04/13/2025 | |
| Frontline Fixed-Duration Therapy in CLL: Improving Outcomes and Tolerability | 04/13/2025 | |
| Risk-Stratification in Newly Diagnosed CLL | 04/12/2025 | |
| Fixed-Duration: A Patient-Captivating Standard of Care in CLL | | |
